From the Heart to the Lung: A Case of Drug Toxicity

Area of Science:

• Cardiology
• Pulmonology
• Pharmacology

Background:

• Amiodarone is a critical anti-arrhythmic medication for managing dysrhythmias.
• It is associated with significant multi-organ toxicity, particularly lung toxicity, affecting 1-5% of patients.
• Pulmonary manifestations range from mild to severe and can be acute, sub-acute, or chronic.

Observation:

• A 71-year-old female on amiodarone 200 mg/day for 18 months presented with amiodarone-induced lung toxicity.
• The patient experienced clinical, functional, and radiological improvement after discontinuing amiodarone.
• Corticosteroid therapy was not administered in this case.

Findings:

• Amiodarone-induced lung toxicity is a diagnosis of exclusion, often requiring drug cessation as the primary treatment.
• Lung disease progression can occur post-discontinuation due to amiodarone's long half-life and tissue accumulation.
• Complete recovery is possible, but the condition can be irreversible or fatal in some instances.

Implications:

• This case suggests that corticosteroid therapy may not be necessary for all instances of amiodarone-induced lung toxicity.
• Emphasizes the importance of considering amiodarone-induced lung toxicity in patients with respiratory symptoms on this medication.
• Highlights the need for careful risk-benefit assessment when prescribing amiodarone, advocating for short-term use whenever possible.